Differential regulation of CYP1A1 and CYP1B1 expression in resveratrol-treated human medulloblastoma cells
- 13 May 2004
- journal article
- research article
- Published by Elsevier
- Vol. 363 (3) , 257-261
- https://doi.org/10.1016/j.neulet.2004.03.075
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Constitutive Expression of CYP1A1 in Bovine Cumulus Oocyte-Complexesin Vitro: Mechanisms and Biological ImplicationsEndocrinology, 2004
- Resveratrol promotes differentiation and induces Fas-independent apoptosis of human medulloblastoma cellsNeuroscience Letters, 2003
- CYP-specific bioactivation of four organophosphorothioate pesticides by human liver microsomesToxicology and Applied Pharmacology, 2003
- Transcriptional Induction of CYP1A1 by Oltipraz in Human Caco-2 Cells Is Aryl Hydrocarbon Receptor- and Calcium-dependentJournal of Biological Chemistry, 2002
- Childhood cancer treatment causes complications later in lifeThe Lancet Oncology, 2002
- The cancer preventative agent resveratrol is converted to the anticancer agent piceatannol by the cytochrome P450 enzyme CYP1B1British Journal of Cancer, 2002
- Piceatannol, a hydroxylated analog of the chemopreventive agent resveratrol, is a potent inducer of apoptosis in the lymphoma cell line BJAB and in primary, leukemic lymphoblastsLeukemia, 2001
- Cytochrome P450 CYP1B1 over-expression in primary and metastatic ovarian cancerBritish Journal of Cancer, 2001
- Cytochrome P450 CYP1B1 protein expression:Biochemical Pharmacology, 2001
- Medulloblastoma: Clinical and biologic aspectsNeuro-Oncology, 1999